Vycor Medical designs, develops and markets medical devices for use in neurosurgery and provides FDA registered diagnostic and therapy products for vision disorders resulting from neurological brain injuries, self-described as offering innovative solutions.

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

COM:VYCORMEDICAL

Vycor Medical

Last Close

0.06

20/11 20:00

Market Cap

2.93M

Beta: -

Volume Today

7.23K

Avg: -

locale

market

industry

website

ipo date

peer of

Metrics